| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myocardium | 64 | 2020 | 1204 | 3.050 |
Why?
|
| Extracellular Matrix | 29 | 2014 | 493 | 2.440 |
Why?
|
| Myocytes, Cardiac | 25 | 2020 | 442 | 1.930 |
Why?
|
| Collagen | 39 | 2014 | 636 | 1.430 |
Why?
|
| Fibroblasts | 29 | 2013 | 902 | 1.330 |
Why?
|
| Heart | 25 | 2015 | 850 | 1.160 |
Why?
|
| Myofibrils | 15 | 2016 | 35 | 0.910 |
Why?
|
| Rats | 79 | 2020 | 5300 | 0.880 |
Why?
|
| Cell Communication | 9 | 2016 | 116 | 0.860 |
Why?
|
| Integrins | 14 | 2002 | 115 | 0.820 |
Why?
|
| Animals | 111 | 2020 | 20881 | 0.730 |
Why?
|
| Cardiovascular Physiological Phenomena | 2 | 2012 | 40 | 0.650 |
Why?
|
| Animals, Newborn | 23 | 2013 | 396 | 0.600 |
Why?
|
| Cardiovascular Diseases | 3 | 2012 | 940 | 0.590 |
Why?
|
| Cells, Cultured | 35 | 2020 | 2673 | 0.520 |
Why?
|
| Cell Culture Techniques | 6 | 2016 | 189 | 0.520 |
Why?
|
| Microscopy | 3 | 2012 | 64 | 0.480 |
Why?
|
| Microscopy, Confocal | 15 | 2016 | 337 | 0.480 |
Why?
|
| Ventricular Remodeling | 4 | 2012 | 318 | 0.440 |
Why?
|
| Fetal Heart | 5 | 1997 | 41 | 0.440 |
Why?
|
| Cytoskeleton | 6 | 2000 | 84 | 0.430 |
Why?
|
| Cell Adhesion | 21 | 2008 | 324 | 0.420 |
Why?
|
| Cardiovascular System | 2 | 2009 | 85 | 0.400 |
Why?
|
| Cell Adhesion Molecules | 4 | 2008 | 199 | 0.390 |
Why?
|
| Sarcomeres | 5 | 2020 | 32 | 0.370 |
Why?
|
| Physical Exertion | 4 | 2002 | 75 | 0.360 |
Why?
|
| Sarcolemma | 4 | 2014 | 16 | 0.340 |
Why?
|
| Signal Transduction | 6 | 2011 | 2689 | 0.340 |
Why?
|
| Rats, Sprague-Dawley | 22 | 2016 | 2083 | 0.340 |
Why?
|
| Receptors, Cell Surface | 5 | 2002 | 248 | 0.330 |
Why?
|
| Integrin beta1 | 7 | 2014 | 48 | 0.310 |
Why?
|
| Models, Biological | 4 | 2016 | 981 | 0.300 |
Why?
|
| Microscopy, Electron, Scanning | 18 | 2004 | 236 | 0.300 |
Why?
|
| Heart Ventricles | 8 | 2016 | 738 | 0.300 |
Why?
|
| Muscles | 8 | 2005 | 158 | 0.300 |
Why?
|
| Myosins | 3 | 2020 | 34 | 0.290 |
Why?
|
| Connective Tissue | 7 | 1985 | 61 | 0.270 |
Why?
|
| Basement Membrane | 3 | 2014 | 48 | 0.270 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2008 | 333 | 0.270 |
Why?
|
| Cardiomegaly | 4 | 2012 | 213 | 0.260 |
Why?
|
| Laminin | 7 | 2014 | 62 | 0.260 |
Why?
|
| Microscopy, Electron | 13 | 2004 | 351 | 0.250 |
Why?
|
| Vinculin | 6 | 1997 | 15 | 0.250 |
Why?
|
| Cell Differentiation | 8 | 2015 | 1034 | 0.250 |
Why?
|
| Gene Expression Regulation | 5 | 2013 | 1293 | 0.250 |
Why?
|
| Stress, Mechanical | 8 | 2020 | 208 | 0.250 |
Why?
|
| Endopeptidases | 1 | 2004 | 52 | 0.230 |
Why?
|
| Hypertension | 4 | 2008 | 1535 | 0.230 |
Why?
|
| Integrin beta Chains | 2 | 2003 | 7 | 0.230 |
Why?
|
| Diagnostic Imaging | 1 | 2005 | 201 | 0.220 |
Why?
|
| Collagenases | 2 | 2014 | 34 | 0.220 |
Why?
|
| Physiological Phenomena | 1 | 2003 | 2 | 0.220 |
Why?
|
| Actins | 7 | 2016 | 249 | 0.220 |
Why?
|
| Stem Cells | 4 | 2016 | 248 | 0.220 |
Why?
|
| Extracellular Matrix Proteins | 2 | 2002 | 144 | 0.220 |
Why?
|
| Mice | 21 | 2014 | 8474 | 0.210 |
Why?
|
| Receptor, Angiotensin, Type 2 | 4 | 2008 | 31 | 0.200 |
Why?
|
| Muscle Cells | 2 | 2011 | 30 | 0.200 |
Why?
|
| Gels | 8 | 2002 | 55 | 0.190 |
Why?
|
| Cell Movement | 6 | 2008 | 630 | 0.190 |
Why?
|
| Aging | 6 | 2013 | 911 | 0.180 |
Why?
|
| Fluorescent Antibody Technique | 10 | 2012 | 282 | 0.180 |
Why?
|
| Motor Activity | 2 | 2002 | 621 | 0.180 |
Why?
|
| Cardiac Myosins | 1 | 2020 | 12 | 0.180 |
Why?
|
| Databases, Factual | 1 | 2003 | 622 | 0.180 |
Why?
|
| Lasers | 4 | 2014 | 61 | 0.170 |
Why?
|
| Microscopy, Fluorescence | 6 | 2014 | 261 | 0.170 |
Why?
|
| Myocardial Contraction | 10 | 2005 | 383 | 0.170 |
Why?
|
| Cytological Techniques | 2 | 2014 | 23 | 0.170 |
Why?
|
| Computer Simulation | 1 | 2003 | 706 | 0.170 |
Why?
|
| Heart Conduction System | 2 | 2006 | 119 | 0.170 |
Why?
|
| Muscle Proteins | 4 | 2014 | 94 | 0.160 |
Why?
|
| Physical Stimulation | 5 | 2002 | 67 | 0.160 |
Why?
|
| Gap Junctions | 3 | 2014 | 29 | 0.160 |
Why?
|
| Lab-On-A-Chip Devices | 2 | 2016 | 18 | 0.160 |
Why?
|
| Intercellular Junctions | 3 | 2013 | 32 | 0.140 |
Why?
|
| Fibronectins | 5 | 1992 | 130 | 0.140 |
Why?
|
| RNA, Messenger | 8 | 2012 | 1664 | 0.140 |
Why?
|
| Mitochondria, Heart | 1 | 2016 | 53 | 0.130 |
Why?
|
| Ventricular Function, Left | 3 | 2008 | 481 | 0.130 |
Why?
|
| Cytoskeletal Proteins | 3 | 1991 | 108 | 0.130 |
Why?
|
| Blotting, Western | 6 | 2008 | 954 | 0.130 |
Why?
|
| Voltage-Sensitive Dye Imaging | 1 | 2015 | 2 | 0.130 |
Why?
|
| Microtomy | 1 | 2015 | 11 | 0.130 |
Why?
|
| Protein Kinase C | 2 | 2007 | 270 | 0.120 |
Why?
|
| Humans | 20 | 2015 | 68618 | 0.120 |
Why?
|
| Cold Temperature | 1 | 2015 | 90 | 0.120 |
Why?
|
| Rats, Inbred Strains | 11 | 1992 | 532 | 0.120 |
Why?
|
| Antigens, CD | 3 | 2000 | 230 | 0.120 |
Why?
|
| Microtechnology | 1 | 2014 | 2 | 0.120 |
Why?
|
| Electrophysiological Phenomena | 1 | 2014 | 20 | 0.120 |
Why?
|
| Calcium Signaling | 1 | 2015 | 97 | 0.120 |
Why?
|
| Copper | 2 | 2004 | 149 | 0.110 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2015 | 86 | 0.110 |
Why?
|
| Cricetinae | 6 | 1983 | 262 | 0.110 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 1993 | 27 | 0.110 |
Why?
|
| Cell Tracking | 1 | 2013 | 3 | 0.110 |
Why?
|
| Myocardial Infarction | 3 | 2011 | 807 | 0.110 |
Why?
|
| Osteonectin | 1 | 2013 | 69 | 0.110 |
Why?
|
| Neoplasms | 1 | 2004 | 1667 | 0.110 |
Why?
|
| Self Stimulation | 4 | 1993 | 6 | 0.110 |
Why?
|
| Muscle Development | 1 | 2012 | 31 | 0.110 |
Why?
|
| Ubiquitins | 1 | 1992 | 22 | 0.100 |
Why?
|
| Interleukin-1 | 1 | 1992 | 86 | 0.100 |
Why?
|
| Desmoplakins | 1 | 2011 | 14 | 0.100 |
Why?
|
| Electric Conductivity | 1 | 2011 | 87 | 0.100 |
Why?
|
| Hematopoietic System | 1 | 2011 | 8 | 0.100 |
Why?
|
| Intestinal Neoplasms | 1 | 2011 | 30 | 0.100 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2003 | 110 | 0.090 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2011 | 46 | 0.090 |
Why?
|
| Receptors, Immunologic | 3 | 2001 | 72 | 0.090 |
Why?
|
| Intestines | 1 | 2011 | 114 | 0.090 |
Why?
|
| Heart Failure | 3 | 2004 | 1180 | 0.090 |
Why?
|
| Models, Cardiovascular | 1 | 2011 | 133 | 0.090 |
Why?
|
| Cartilage | 2 | 1981 | 51 | 0.090 |
Why?
|
| Adenoma | 1 | 2011 | 132 | 0.090 |
Why?
|
| Extracellular Space | 1 | 2010 | 121 | 0.090 |
Why?
|
| Heart Septum | 1 | 1990 | 84 | 0.090 |
Why?
|
| Tumor Microenvironment | 1 | 2011 | 213 | 0.090 |
Why?
|
| Cell Size | 3 | 2005 | 76 | 0.080 |
Why?
|
| Physical Conditioning, Animal | 3 | 2002 | 34 | 0.080 |
Why?
|
| Equipment Failure Analysis | 2 | 2016 | 121 | 0.080 |
Why?
|
| Electrophysiology | 2 | 2006 | 160 | 0.080 |
Why?
|
| Membranes, Artificial | 3 | 2002 | 88 | 0.080 |
Why?
|
| Sarcoma, Experimental | 1 | 1988 | 5 | 0.080 |
Why?
|
| Tumor Cells, Cultured | 2 | 2000 | 852 | 0.080 |
Why?
|
| Actinin | 3 | 2014 | 9 | 0.080 |
Why?
|
| Rabbits | 5 | 2015 | 509 | 0.080 |
Why?
|
| Fibrosis | 2 | 2007 | 371 | 0.080 |
Why?
|
| Cell Membrane | 5 | 2013 | 525 | 0.080 |
Why?
|
| Calibration | 2 | 2005 | 73 | 0.080 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 1988 | 153 | 0.070 |
Why?
|
| Cell Line | 5 | 2001 | 1752 | 0.070 |
Why?
|
| Macrophages | 3 | 2001 | 647 | 0.070 |
Why?
|
| Cicatrix | 1 | 2007 | 60 | 0.070 |
Why?
|
| Wound Healing | 2 | 2006 | 260 | 0.070 |
Why?
|
| Dopamine | 2 | 1991 | 474 | 0.070 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2003 | 689 | 0.070 |
Why?
|
| Biomechanical Phenomena | 2 | 2006 | 368 | 0.070 |
Why?
|
| Protein Structure, Tertiary | 2 | 2004 | 322 | 0.070 |
Why?
|
| Tissue Engineering | 2 | 2020 | 212 | 0.070 |
Why?
|
| Gestational Age | 3 | 1997 | 389 | 0.070 |
Why?
|
| Blood Pressure | 4 | 2008 | 1451 | 0.070 |
Why?
|
| In Vitro Techniques | 4 | 2015 | 765 | 0.060 |
Why?
|
| Isoenzymes | 1 | 2007 | 308 | 0.060 |
Why?
|
| Embryonic and Fetal Development | 2 | 1997 | 74 | 0.060 |
Why?
|
| Equipment Design | 3 | 2016 | 500 | 0.060 |
Why?
|
| Time Factors | 5 | 2005 | 4655 | 0.060 |
Why?
|
| Biomedical Engineering | 1 | 2005 | 20 | 0.060 |
Why?
|
| Up-Regulation | 1 | 2007 | 682 | 0.060 |
Why?
|
| Trientine | 1 | 2004 | 1 | 0.060 |
Why?
|
| Discoidin Domain Receptors | 1 | 2004 | 16 | 0.060 |
Why?
|
| Implants, Experimental | 1 | 2004 | 15 | 0.060 |
Why?
|
| Immunohistochemistry | 3 | 2013 | 1174 | 0.060 |
Why?
|
| Ribonucleases | 1 | 2004 | 25 | 0.060 |
Why?
|
| Receptors, Mitogen | 1 | 2004 | 23 | 0.060 |
Why?
|
| Platelet-Derived Growth Factor | 2 | 1998 | 45 | 0.060 |
Why?
|
| Connexins | 1 | 2004 | 35 | 0.060 |
Why?
|
| Chelating Agents | 1 | 2004 | 47 | 0.060 |
Why?
|
| Ventricular Function | 2 | 2003 | 93 | 0.060 |
Why?
|
| Positron-Emission Tomography | 1 | 2005 | 160 | 0.060 |
Why?
|
| Diabetes Complications | 1 | 2006 | 249 | 0.060 |
Why?
|
| Freeze Fracturing | 2 | 1981 | 11 | 0.060 |
Why?
|
| Biosensing Techniques | 1 | 2004 | 51 | 0.060 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2004 | 100 | 0.060 |
Why?
|
| Receptors, Collagen | 5 | 1990 | 9 | 0.060 |
Why?
|
| DNA Probes | 2 | 1994 | 57 | 0.060 |
Why?
|
| Connexin 43 | 1 | 2004 | 62 | 0.060 |
Why?
|
| Blood | 2 | 1990 | 40 | 0.060 |
Why?
|
| Human Genome Project | 1 | 2003 | 4 | 0.060 |
Why?
|
| Liver | 5 | 1990 | 1118 | 0.050 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2004 | 144 | 0.050 |
Why?
|
| Phorbol Esters | 1 | 2003 | 37 | 0.050 |
Why?
|
| Physiology | 1 | 2003 | 12 | 0.050 |
Why?
|
| Mice, Knockout | 1 | 2007 | 1692 | 0.050 |
Why?
|
| Neovascularization, Pathologic | 1 | 2004 | 183 | 0.050 |
Why?
|
| Genome | 1 | 2003 | 54 | 0.050 |
Why?
|
| Protease Inhibitors | 1 | 2003 | 76 | 0.050 |
Why?
|
| Matrix Metalloproteinase Inhibitors | 1 | 2003 | 59 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 710 | 0.050 |
Why?
|
| Precipitin Tests | 2 | 1994 | 88 | 0.050 |
Why?
|
| Cell Separation | 1 | 2003 | 132 | 0.050 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2003 | 106 | 0.050 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2004 | 235 | 0.050 |
Why?
|
| Wounds and Injuries | 1 | 2006 | 334 | 0.050 |
Why?
|
| Proteome | 1 | 2003 | 87 | 0.050 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2004 | 195 | 0.050 |
Why?
|
| Weight-Bearing | 1 | 2002 | 53 | 0.050 |
Why?
|
| Male | 16 | 2015 | 37321 | 0.050 |
Why?
|
| Dysgerminoma | 1 | 1982 | 9 | 0.050 |
Why?
|
| Molecular Sequence Data | 5 | 2001 | 1447 | 0.050 |
Why?
|
| Adaptation, Physiological | 1 | 2003 | 189 | 0.050 |
Why?
|
| Staining and Labeling | 2 | 2012 | 144 | 0.050 |
Why?
|
| Kinetics | 4 | 2015 | 1047 | 0.050 |
Why?
|
| Angiotensin II | 2 | 2004 | 220 | 0.050 |
Why?
|
| Hypertrophy, Left Ventricular | 2 | 2000 | 140 | 0.050 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2003 | 507 | 0.050 |
Why?
|
| Epiphyses | 1 | 1981 | 5 | 0.050 |
Why?
|
| Coculture Techniques | 2 | 2013 | 147 | 0.050 |
Why?
|
| Heart Rate | 4 | 1997 | 568 | 0.050 |
Why?
|
| Blotting, Northern | 2 | 2008 | 189 | 0.050 |
Why?
|
| Antibodies | 2 | 1992 | 241 | 0.050 |
Why?
|
| Oligonucleotides, Antisense | 2 | 1997 | 48 | 0.050 |
Why?
|
| Fluorescent Dyes | 2 | 2013 | 191 | 0.040 |
Why?
|
| Ventricular Myosins | 1 | 2020 | 7 | 0.040 |
Why?
|
| Pregnancy | 4 | 2007 | 2334 | 0.040 |
Why?
|
| Diabetes Mellitus | 1 | 2006 | 694 | 0.040 |
Why?
|
| Mitochondria | 2 | 2016 | 643 | 0.040 |
Why?
|
| Immune Sera | 4 | 1995 | 30 | 0.040 |
Why?
|
| Calcineurin Inhibitors | 1 | 1999 | 24 | 0.040 |
Why?
|
| Endothelium | 2 | 2010 | 98 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 2 | 1992 | 511 | 0.040 |
Why?
|
| Cyclosporine | 1 | 1999 | 121 | 0.040 |
Why?
|
| Mice, Transgenic | 3 | 2008 | 1033 | 0.040 |
Why?
|
| Aortic Valve Stenosis | 1 | 2000 | 177 | 0.040 |
Why?
|
| Receptors, Angiotensin | 2 | 1997 | 59 | 0.040 |
Why?
|
| Organ Size | 2 | 1996 | 242 | 0.040 |
Why?
|
| Motivation | 2 | 1991 | 561 | 0.040 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 1997 | 155 | 0.040 |
Why?
|
| Morphogenesis | 2 | 1997 | 159 | 0.030 |
Why?
|
| Calcium | 3 | 1985 | 929 | 0.030 |
Why?
|
| Guinea Pigs | 2 | 2015 | 124 | 0.030 |
Why?
|
| Isoproterenol | 2 | 2004 | 163 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2005 | 2223 | 0.030 |
Why?
|
| Contractile Proteins | 1 | 1996 | 17 | 0.030 |
Why?
|
| Cell Surface Extensions | 1 | 2016 | 5 | 0.030 |
Why?
|
| Perfusion | 2 | 2015 | 131 | 0.030 |
Why?
|
| Body Weight | 2 | 1996 | 554 | 0.030 |
Why?
|
| Heterocyclic Compounds, 4 or More Rings | 1 | 2016 | 34 | 0.030 |
Why?
|
| Nanotubes | 1 | 2016 | 22 | 0.030 |
Why?
|
| Base Sequence | 2 | 1995 | 1015 | 0.030 |
Why?
|
| Glycoproteins | 3 | 1986 | 238 | 0.030 |
Why?
|
| Diastole | 1 | 1996 | 161 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2016 | 219 | 0.030 |
Why?
|
| Silicon | 1 | 2015 | 20 | 0.030 |
Why?
|
| Nanowires | 1 | 2015 | 11 | 0.030 |
Why?
|
| Hemodynamics | 2 | 2000 | 705 | 0.030 |
Why?
|
| Infant, Newborn | 2 | 2014 | 2455 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2005 | 2324 | 0.030 |
Why?
|
| Heart Atria | 3 | 1996 | 206 | 0.030 |
Why?
|
| Tissue Survival | 1 | 2015 | 22 | 0.030 |
Why?
|
| Culture Media | 2 | 1988 | 155 | 0.030 |
Why?
|
| Chickens | 3 | 1981 | 232 | 0.030 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2015 | 100 | 0.030 |
Why?
|
| Microscopy, Immunoelectron | 1 | 1994 | 27 | 0.030 |
Why?
|
| Molecular Probes | 1 | 1994 | 27 | 0.030 |
Why?
|
| Tissue Scaffolds | 1 | 2015 | 111 | 0.030 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2015 | 174 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 1 | 1994 | 196 | 0.030 |
Why?
|
| Procollagen | 1 | 2013 | 31 | 0.030 |
Why?
|
| Solubility | 1 | 2013 | 134 | 0.030 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2014 | 54 | 0.030 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 1994 | 144 | 0.030 |
Why?
|
| Action Potentials | 1 | 2015 | 223 | 0.030 |
Why?
|
| CD57 Antigens | 1 | 1993 | 3 | 0.030 |
Why?
|
| Hormones | 1 | 1993 | 42 | 0.030 |
Why?
|
| Sinoatrial Node | 1 | 1993 | 14 | 0.030 |
Why?
|
| In Situ Hybridization | 1 | 1993 | 201 | 0.030 |
Why?
|
| Cell Fusion | 1 | 2013 | 23 | 0.030 |
Why?
|
| Atrioventricular Node | 1 | 1993 | 39 | 0.030 |
Why?
|
| Single-Cell Analysis | 1 | 2013 | 35 | 0.030 |
Why?
|
| Collagen Type I | 1 | 2013 | 175 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 1994 | 492 | 0.030 |
Why?
|
| Endocardium | 1 | 1992 | 101 | 0.030 |
Why?
|
| Indoles | 1 | 2013 | 146 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 1994 | 562 | 0.020 |
Why?
|
| Constriction, Pathologic | 1 | 2012 | 236 | 0.020 |
Why?
|
| Dimethylpolysiloxanes | 1 | 2011 | 7 | 0.020 |
Why?
|
| Mesoderm | 1 | 1992 | 231 | 0.020 |
Why?
|
| Phenotype | 1 | 1994 | 947 | 0.020 |
Why?
|
| Osmolar Concentration | 2 | 2004 | 134 | 0.020 |
Why?
|
| Receptor, Angiotensin, Type 1 | 2 | 2004 | 80 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2015 | 506 | 0.020 |
Why?
|
| Osteopontin | 1 | 2011 | 28 | 0.020 |
Why?
|
| Female | 8 | 2015 | 38074 | 0.020 |
Why?
|
| Patch-Clamp Techniques | 1 | 2011 | 204 | 0.020 |
Why?
|
| Histocytochemistry | 2 | 1993 | 149 | 0.020 |
Why?
|
| Receptors, Scavenger | 2 | 2001 | 13 | 0.020 |
Why?
|
| Electrodes | 1 | 2011 | 147 | 0.020 |
Why?
|
| Antibody Specificity | 1 | 1990 | 98 | 0.020 |
Why?
|
| Protein Denaturation | 2 | 2001 | 27 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2011 | 200 | 0.020 |
Why?
|
| DNA | 1 | 1993 | 597 | 0.020 |
Why?
|
| Aorta, Thoracic | 1 | 2012 | 211 | 0.020 |
Why?
|
| Bone Marrow Transplantation | 1 | 2011 | 149 | 0.020 |
Why?
|
| Asialoglycoproteins | 1 | 1990 | 4 | 0.020 |
Why?
|
| Fluoresceins | 1 | 1990 | 31 | 0.020 |
Why?
|
| Ethylenediamines | 1 | 1990 | 5 | 0.020 |
Why?
|
| Cats | 1 | 1990 | 292 | 0.020 |
Why?
|
| Serum Albumin | 2 | 1990 | 104 | 0.020 |
Why?
|
| Blood Proteins | 1 | 1990 | 94 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2010 | 127 | 0.020 |
Why?
|
| Mice, Inbred Strains | 2 | 2000 | 181 | 0.020 |
Why?
|
| Talin | 1 | 1989 | 3 | 0.020 |
Why?
|
| Biocompatible Materials | 1 | 2011 | 247 | 0.020 |
Why?
|
| Myosin Heavy Chains | 2 | 1999 | 49 | 0.020 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 1988 | 13 | 0.020 |
Why?
|
| Cell Aggregation | 1 | 1988 | 28 | 0.020 |
Why?
|
| Pheochromocytoma | 1 | 1988 | 22 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2010 | 330 | 0.020 |
Why?
|
| Amino Acid Sequence | 3 | 2001 | 1083 | 0.020 |
Why?
|
| Iodocyanopindolol | 1 | 1988 | 6 | 0.020 |
Why?
|
| Pindolol | 1 | 1988 | 52 | 0.020 |
Why?
|
| Surface Tension | 1 | 1988 | 13 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2012 | 1174 | 0.020 |
Why?
|
| Radioligand Assay | 1 | 1988 | 109 | 0.020 |
Why?
|
| Atrial Natriuretic Factor | 1 | 2008 | 54 | 0.020 |
Why?
|
| Electrodes, Implanted | 3 | 1993 | 98 | 0.020 |
Why?
|
| Hydroxyproline | 1 | 2007 | 33 | 0.020 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2008 | 101 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 2077 | 0.020 |
Why?
|
| Cyclic AMP | 1 | 1988 | 223 | 0.020 |
Why?
|
| Protein Kinase C-delta | 1 | 2007 | 12 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2010 | 626 | 0.020 |
Why?
|
| Protein Kinase C-epsilon | 1 | 2007 | 28 | 0.020 |
Why?
|
| Protein Kinase C-alpha | 1 | 2007 | 24 | 0.020 |
Why?
|
| Cell Count | 1 | 2007 | 248 | 0.020 |
Why?
|
| Membrane Glycoproteins | 1 | 1989 | 370 | 0.020 |
Why?
|
| Adult | 4 | 2014 | 21403 | 0.020 |
Why?
|
| Fetus | 1 | 2007 | 157 | 0.020 |
Why?
|
| Tyramine | 1 | 1986 | 16 | 0.020 |
Why?
|
| Age Factors | 2 | 1982 | 1864 | 0.020 |
Why?
|
| Antigens, Surface | 1 | 1986 | 71 | 0.020 |
Why?
|
| Culture Techniques | 2 | 1997 | 65 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2007 | 489 | 0.020 |
Why?
|
| Conditioning, Operant | 3 | 1993 | 241 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 1989 | 597 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2008 | 714 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2012 | 2791 | 0.020 |
Why?
|
| Protein-Lysine 6-Oxidase | 1 | 1985 | 14 | 0.020 |
Why?
|
| Brain | 2 | 1993 | 2176 | 0.020 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2007 | 317 | 0.020 |
Why?
|
| Endothelium, Vascular | 1 | 2007 | 371 | 0.020 |
Why?
|
| Oligopeptides | 3 | 1990 | 152 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2012 | 2550 | 0.020 |
Why?
|
| Ammonium Chloride | 1 | 2004 | 4 | 0.020 |
Why?
|
| Neovascularization, Physiologic | 1 | 2006 | 164 | 0.020 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2004 | 23 | 0.020 |
Why?
|
| Calcium-Transporting ATPases | 1 | 2004 | 40 | 0.020 |
Why?
|
| Edema | 1 | 2005 | 66 | 0.020 |
Why?
|
| Tissue Distribution | 2 | 2000 | 282 | 0.020 |
Why?
|
| Sheep | 1 | 2005 | 128 | 0.020 |
Why?
|
| Membrane Proteins | 2 | 1986 | 617 | 0.020 |
Why?
|
| Compliance | 2 | 1981 | 26 | 0.010 |
Why?
|
| Proteoglycans | 1 | 1985 | 103 | 0.010 |
Why?
|
| Cardiotonic Agents | 1 | 2004 | 71 | 0.010 |
Why?
|
| Cholesterol | 1 | 1985 | 331 | 0.010 |
Why?
|
| Calcium-Binding Proteins | 1 | 2004 | 114 | 0.010 |
Why?
|
| Necrosis | 1 | 2005 | 239 | 0.010 |
Why?
|
| Peptide Fragments | 2 | 2001 | 483 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2007 | 1200 | 0.010 |
Why?
|
| Electric Impedance | 1 | 2004 | 131 | 0.010 |
Why?
|
| Patient Care Team | 1 | 2006 | 311 | 0.010 |
Why?
|
| Myosin Light Chains | 1 | 2003 | 18 | 0.010 |
Why?
|
| Regeneration | 1 | 2004 | 105 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 2004 | 371 | 0.010 |
Why?
|
| Ischemia | 1 | 2005 | 229 | 0.010 |
Why?
|
| Corticosterone | 2 | 1993 | 51 | 0.010 |
Why?
|
| Mesocricetus | 1 | 1982 | 32 | 0.010 |
Why?
|
| Diabetic Angiopathies | 1 | 2004 | 203 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2004 | 618 | 0.010 |
Why?
|
| Temperature | 1 | 1984 | 341 | 0.010 |
Why?
|
| Biological Assay | 1 | 2003 | 88 | 0.010 |
Why?
|
| Norepinephrine | 2 | 1993 | 276 | 0.010 |
Why?
|
| Recombinant Proteins | 2 | 1998 | 742 | 0.010 |
Why?
|
| Cell Survival | 1 | 1985 | 901 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2003 | 532 | 0.010 |
Why?
|
| Microvilli | 1 | 1982 | 22 | 0.010 |
Why?
|
| Anisotropy | 1 | 2002 | 105 | 0.010 |
Why?
|
| Cell Membrane Permeability | 1 | 1982 | 59 | 0.010 |
Why?
|
| Coronary Vessels | 1 | 2004 | 313 | 0.010 |
Why?
|
| Organoids | 1 | 1982 | 42 | 0.010 |
Why?
|
| Potassium | 1 | 1982 | 168 | 0.010 |
Why?
|
| Glycosaminoglycans | 1 | 1982 | 88 | 0.010 |
Why?
|
| Microtubules | 1 | 1982 | 104 | 0.010 |
Why?
|
| Scavenger Receptors, Class A | 1 | 2001 | 3 | 0.010 |
Why?
|
| Calcification, Physiologic | 1 | 1981 | 31 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2003 | 615 | 0.010 |
Why?
|
| Pericardium | 1 | 1981 | 97 | 0.010 |
Why?
|
| Species Specificity | 1 | 1981 | 303 | 0.010 |
Why?
|
| Gene Expression | 1 | 2003 | 770 | 0.010 |
Why?
|
| Cardiac Output, Low | 1 | 2000 | 52 | 0.010 |
Why?
|
| CD18 Antigens | 1 | 2000 | 9 | 0.010 |
Why?
|
| Integrin alphaV | 1 | 2000 | 3 | 0.010 |
Why?
|
| Receptors, Vitronectin | 1 | 2000 | 11 | 0.010 |
Why?
|
| Heating | 1 | 2000 | 13 | 0.010 |
Why?
|
| Cattle | 1 | 2001 | 475 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 2001 | 420 | 0.010 |
Why?
|
| Cell Division | 1 | 1981 | 541 | 0.010 |
Why?
|
| Chromones | 1 | 2000 | 33 | 0.010 |
Why?
|
| Mice, Inbred C3H | 1 | 2000 | 134 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 1990 | 272 | 0.010 |
Why?
|
| Morpholines | 1 | 2000 | 79 | 0.010 |
Why?
|
| Inflammation | 1 | 2006 | 1030 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2001 | 376 | 0.010 |
Why?
|
| Binding Sites | 1 | 2001 | 631 | 0.010 |
Why?
|
| Calcineurin | 1 | 1999 | 13 | 0.010 |
Why?
|
| Flavonoids | 1 | 2000 | 109 | 0.010 |
Why?
|
| Papillary Muscles | 1 | 1979 | 30 | 0.010 |
Why?
|
| Transfection | 1 | 2001 | 782 | 0.010 |
Why?
|
| Ligation | 1 | 1999 | 83 | 0.010 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2000 | 195 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2001 | 546 | 0.010 |
Why?
|
| Muscle Contraction | 1 | 1999 | 210 | 0.010 |
Why?
|
| Ligands | 1 | 2000 | 317 | 0.010 |
Why?
|
| Oxygen Consumption | 2 | 1993 | 258 | 0.010 |
Why?
|
| Electric Stimulation | 2 | 1993 | 218 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 1998 | 25 | 0.010 |
Why?
|
| Matrix Metalloproteinases | 1 | 2000 | 223 | 0.010 |
Why?
|
| Protein Binding | 1 | 2001 | 1027 | 0.010 |
Why?
|
| Losartan | 1 | 1997 | 45 | 0.010 |
Why?
|
| Random Allocation | 1 | 1999 | 442 | 0.010 |
Why?
|
| Hypertrophy | 1 | 1997 | 89 | 0.010 |
Why?
|
| Organ Culture Techniques | 1 | 1997 | 122 | 0.010 |
Why?
|
| Molecular Weight | 2 | 1989 | 358 | 0.010 |
Why?
|
| Aorta | 1 | 1999 | 316 | 0.010 |
Why?
|
| Echocardiography | 1 | 2000 | 515 | 0.010 |
Why?
|
| Imidazoles | 1 | 1997 | 175 | 0.010 |
Why?
|
| Disease Progression | 1 | 2000 | 1038 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2000 | 659 | 0.010 |
Why?
|
| Truncus Arteriosus | 1 | 1996 | 5 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 1997 | 176 | 0.010 |
Why?
|
| Down-Regulation | 1 | 1998 | 447 | 0.010 |
Why?
|
| Integrin alpha1 | 1 | 1995 | 5 | 0.010 |
Why?
|
| Integrin alpha1beta1 | 1 | 1995 | 5 | 0.010 |
Why?
|
| Oligonucleotide Probes | 1 | 1995 | 35 | 0.010 |
Why?
|
| Quail | 1 | 1995 | 27 | 0.010 |
Why?
|
| Pyridines | 1 | 1997 | 261 | 0.010 |
Why?
|
| Nifedipine | 1 | 1995 | 40 | 0.010 |
Why?
|
| Chick Embryo | 1 | 1995 | 379 | 0.010 |
Why?
|
| Chloroquine | 1 | 1993 | 21 | 0.010 |
Why?
|
| Verapamil | 1 | 1993 | 30 | 0.010 |
Why?
|
| Apoptosis | 1 | 2000 | 1641 | 0.010 |
Why?
|
| Epinephrine | 1 | 1993 | 103 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1993 | 138 | 0.010 |
Why?
|
| Membrane Potentials | 1 | 1993 | 200 | 0.010 |
Why?
|
| Body Temperature | 1 | 1993 | 116 | 0.010 |
Why?
|
| Electroshock | 1 | 1991 | 36 | 0.010 |
Why?
|
| Stereotaxic Techniques | 1 | 1991 | 35 | 0.010 |
Why?
|
| Tegmentum Mesencephali | 1 | 1991 | 52 | 0.010 |
Why?
|
| Avoidance Learning | 1 | 1991 | 58 | 0.010 |
Why?
|
| Limbic System | 1 | 1991 | 106 | 0.010 |
Why?
|
| Edetic Acid | 1 | 1990 | 29 | 0.010 |
Why?
|
| Fetuins | 1 | 1990 | 2 | 0.010 |
Why?
|
| Glycoconjugates | 1 | 1990 | 22 | 0.010 |
Why?
|
| alpha-Fetoproteins | 1 | 1990 | 22 | 0.010 |
Why?
|
| Chromatography, Gel | 1 | 1990 | 79 | 0.010 |
Why?
|
| Half-Life | 1 | 1990 | 96 | 0.010 |
Why?
|
| Transforming Growth Factors | 1 | 1990 | 12 | 0.010 |
Why?
|
| United States | 1 | 2002 | 7367 | 0.010 |
Why?
|
| Cyanogen Bromide | 1 | 1989 | 14 | 0.010 |
Why?
|
| Peptide Mapping | 1 | 1989 | 39 | 0.010 |
Why?
|
| Neural Pathways | 1 | 1991 | 324 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 1990 | 481 | 0.000 |
Why?
|
| Skin | 1 | 1990 | 451 | 0.000 |
Why?
|
| Radioisotope Dilution Technique | 1 | 1986 | 14 | 0.000 |
Why?
|
| Metabolic Clearance Rate | 1 | 1986 | 48 | 0.000 |
Why?
|
| Autoradiography | 1 | 1986 | 94 | 0.000 |
Why?
|
| Chromatography, Affinity | 1 | 1986 | 73 | 0.000 |
Why?
|
| Iodine Radioisotopes | 1 | 1986 | 119 | 0.000 |
Why?
|
| Phosphocreatine | 1 | 1984 | 20 | 0.000 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 1984 | 67 | 0.000 |
Why?
|
| Arthritis | 1 | 1984 | 53 | 0.000 |
Why?
|
| Adenosine Triphosphate | 1 | 1984 | 314 | 0.000 |
Why?
|
| Water-Electrolyte Balance | 1 | 1982 | 43 | 0.000 |
Why?
|
| Muscle Relaxation | 1 | 1981 | 31 | 0.000 |
Why?
|
| Dogs | 1 | 1981 | 490 | 0.000 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1982 | 1745 | 0.000 |
Why?
|